Minor/Significance Unknown. Minor (1)acetazolamide increases levels of lomitapide by affecting hepatic/intestinal enzyme CYP3A4 metabolism. acetazolamide will increase the level or effect of ivosidenib by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor (1)acetazolamide will increase the level or effect of ergotamine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. acetazolamide will increase the level or effect of fluticasone inhaled by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Monitor Closely (2)acetazolamide, aspirin rectal. Your doctor may adjust your dose as needed. Minor/Significance Unknown. Minor (1)acetazolamide will increase the level or effect of palbociclib by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Acetazolamide is the mainstay of medical therapy for idiopathic intracranial hypertension (IIH). Use Caution/Monitor. tablet 125mg 250mg vial 500mg Typical dosing for acetazolamide Immediate-release pill The dose varies according to why you're taking this medication, but the typical dose starts at 250 mg to 375 mg by mouth once daily. Minor/Significance Unknown. Minor (1)acetazolamide will increase the level or effect of lansoprazole by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown. According to Wilderness Medical Society Consensus Guidelines, while higher doses are effective they are associated with more frequent and/or increased side effects. Take your next dose at the regular time. Minor/Significance Unknown. acetazolamide will increase the level or effect of trabectedin by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown. Minor/Significance Unknown. Minor/Significance Unknown. Minor/Significance Unknown. acetazolamide, willow bark. Consult your pharmacist or local waste disposal company. Minor/Significance Unknown. Not all forms of this medication work the same way.Do not share this medication with others.Lab and/or medical tests (such as complete blood count, potassium and sodium levels in the blood, liver function tests) may be done while you are using this medication. Coadministration increases risk of CNS depression, which can lead to additive impairment of psychomotor performance and cause daytime impairment. Minor (1)acetazolamide will increase the level or effect of cariprazine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. acetazolamide will increase the level or effect of guanfacine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown. Minor/Significance Unknown. Comment: Carbonic anhydrase inhibitors (CAIs) and salicylates inhibit each other's renal tubular secretion, resulting in increased plasma levels. Most Minor/Significance Unknown. Minor/Significance Unknown. acetazolamide will increase the level or effect of osilodrostat by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown. Minor (1)acetazolamide will increase the level or effect of ticlopidine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. CAIs also shift salicylates from plasma to the CNS, leading to potential neurotoxicity. Minor/Significance Unknown. Minor/Significance Unknown. acetazolamide will increase the level or effect of dronedarone by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor (1)acetazolamide will increase the level or effect of riociguat by affecting hepatic/intestinal enzyme CYP3A4 metabolism. acetazolamide will increase the level or effect of verapamil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown. Use Caution/Monitor. Minor (1)acetazolamide will increase the level or effect of ethosuximide by affecting hepatic/intestinal enzyme CYP3A4 metabolism. acetazolamide decreases levels of acetaminophen rectal by increasing metabolism. Queens of the Stone Age will bring Phantogram, Viagra Boys, the Armed, and Savages' Jehnny Beth on their fall North American tour. All material on this website is protected by copyright, Copyright 1994-2023 by WebMD LLC. Use Caution/Monitor. Minor/Significance Unknown. Mechanism: passive renal tubular reabsorption due to increased pH. Minor (1)acetazolamide will increase the level or effect of umeclidinium bromide/vilanterol inhaled by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press. Minor (1)acetazolamide will increase the level or effect of pexidartinib by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown. commonly, these are "non-preferred" brand drugs. acetazolamide will increase the level or effect of fenofibric acid by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown. Minor (1)acetazolamide will increase the level or effect of doravirine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown. Serious - Use Alternative (1)acetazolamide and olopatadine intranasal both increase sedation. Minor (1)acetazolamide will increase the level or effect of lopinavir by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Below, check out the tour dates, as well as a weird tour . You may report side effects to Health Canada at 1-866-234-2345. Minor (1)acetazolamide will increase the level or effect of flibanserin by affecting hepatic/intestinal enzyme CYP3A4 metabolism. acetazolamide will increase the level or effect of tadalafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Monitor for efficacy of amantadine. Minor/Significance Unknown. Minor/Significance Unknown. Minor/Significance Unknown. Consult your doctor for more information.Tell your doctor if your condition lasts or gets worse. Minor/Significance Unknown. acetazolamide will increase the level or effect of buprenorphine transdermal by affecting hepatic/intestinal enzyme CYP3A4 metabolism. acetazolamide will increase the level or effect of clarithromycin by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor (1)acetazolamide will increase the level or effect of fluticasone furoate by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown. Minor/Significance Unknown. Minor/Significance Unknown. Minor/Significance Unknown. Salicylate levels increased at moderate doses; risk of CNS toxicity. Minor/Significance Unknown. Comment: Carbonic anhydrase inhibitors (CAIs) and salicylates inhibit each other's renal tubular secretion, resulting in increased plasma levels. Minor (1)acetazolamide will increase the level or effect of marijuana by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown. The above information is provided for general acetazolamide decreases levels of trientine by increasing renal clearance. Minor (1)acetazolamide will increase the level or effect of elvitegravir by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor (1)acetazolamide will increase the level or effect of polatuzumab vedotin by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor (1)acetazolamide will increase the level or effect of tetracycline by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown. acetazolamide, amobarbital. Monitor Closely (1)nitazoxanide, acetazolamide. Minor/Significance Unknown. Minor/Significance Unknown. Minor/Significance Unknown. Minor/Significance Unknown. Minor/Significance Unknown. Minor/Significance Unknown. Minor/Significance Unknown. Minor/Significance Unknown. Increased risk of anticonvulsant induced osteomalacia. Minor/Significance Unknown. Minor/Significance Unknown. acetazolamide will increase the level or effect of colchicine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. 10. informational and educational purposes only. Minor (1)acetazolamide will increase the level or effect of progesterone intravaginal gel by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor (1)acetazolamide will increase the level or effect of felbamate by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown. dichlorphenamide and acetazolamide both decrease serum potassium. acetazolamide will increase the level or effect of aprepitant by affecting hepatic/intestinal enzyme CYP3A4 metabolism. DESCRIPTION Carbonic anhydrase inhibitor; acetazolamide is used for high-altitude sickness, and as an adjunct treatment for glaucoma and epilepsy. Mechanism: passive renal tubular reabsorption due to increased pH. Minor/Significance Unknown. Minor/Significance Unknown. Minor (1)acetazolamide will increase the level or effect of bedaquiline by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor (1)acetazolamide will increase the level or effect of dexlansoprazole by affecting hepatic/intestinal enzyme CYP3A4 metabolism. For seizures (in combination with other anticonvulsants): Adults250 milligrams (mg) once a day. Increased risk of anticonvulsant induced osteomalacia. For secondary and acute closed-angle glaucoma: Adults250 milligrams (mg) every 4 hours or 2 times a day. Minor (1)acetazolamide will increase the level or effect of etoposide by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown. Minor/Significance Unknown. acetazolamide will increase the level or effect of velpatasvir by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Increased risk of anticonvulsant induced osteomalacia. Minor/Significance Unknown. Mechanism: pharmacodynamic synergism. Minor/Significance Unknown. Minor (1)acetazolamide will increase the level or effect of isradipine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown. CAIs also shift salicylates from plasma to the CNS, leading to potential neurotoxicity. Minor/Significance Unknown. Mechanism: pharmacodynamic synergism. Comment: Carbonic anhydrase inhibitors (CAIs) and salicylates inhibit each other's renal tubular secretion, resulting in increased plasma levels. Otherwise, call a poison control center right away. Your doctor may also prescribe a potassium supplement for you to take during treatment. Minor (1)acetazolamide will increase the level or effect of elagolix by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown. Minor (1)acetazolamide will increase the level or effect of lapatinib by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown. acetazolamide will increase the level or effect of trimipramine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor (1)acetazolamide will increase the level or effect of pomalidomide by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown. Minor/Significance Unknown. Minor/Significance Unknown. Use Caution/Monitor. acetazolamide, sulfasalazine. Salicylate levels decreased at large doses (d/t increased renal excretion of unchanged salicylic acid).Minor (1)aspirin will decrease the level or effect of acetazolamide by affecting hepatic/intestinal enzyme CYP3A4 metabolism. prescription products. acetazolamide will increase the level or effect of bedaquiline by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Adults250 to 375 milligrams (mg) once a day for one or 2 days, with a rest day in between. Minor/Significance Unknown. Minor/Significance Unknown. Safety and efficacy of extended-release (ER) capsules have not been established in patients younger than 12 years. Salicylate levels increased at moderate doses; risk of CNS toxicity. Monitor Closely (1)nitroglycerin rectal, acetazolamide. acetazolamide will increase the level or effect of haloperidol by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown. Minor/Significance Unknown. Minor/Significance Unknown. acetazolamide will increase the level or effect of tolterodine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. acetazolamide will increase the level or effect of voriconazole by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor (1)acetazolamide will increase the level or effect of vinorelbine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Comment: Carbonic anhydrase inhibitors (CAIs) and salicylates inhibit each other's renal tubular secretion, resulting in increased plasma levels. Comments: 12 years or older: acetazolamide will increase the level or effect of ruxolitinib topical by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown. acetazolamide will increase the level or effect of flecainide by passive renal tubular reabsorption - basic urine. Monitor blood pressure and adjust dose of antihypertensive agent as needed.Minor (1)acetazolamide will increase the level or effect of lurasidone by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown. Minor/Significance Unknown. acetazolamide will increase the level or effect of mifepristone by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor (1)acetazolamide will increase the level or effect of dasatinib by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor. Minor/Significance Unknown. Minor/Significance Unknown. Minor (1)acetazolamide will increase the level or effect of doxorubicin liposomal by affecting hepatic/intestinal enzyme CYP3A4 metabolism. acetazolamide will increase the level or effect of ciclesonide inhaled by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Mechanism: passive renal tubular reabsorption due to increased pH. Minor (1)acetazolamide will increase the level or effect of perampanel by affecting hepatic/intestinal enzyme CYP3A4 metabolism. acetazolamide will increase the level or effect of rabeprazole by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown. Minor/Significance Unknown. Use Caution/Monitor. Minor (1)acetazolamide will increase the level or effect of ticagrelor by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor (1)acetazolamide will increase the level or effect of osilodrostat by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown. acetazolamide will increase the level or effect of ruxolitinib by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor (1)acetazolamide will increase the level or effect of elbasvir/grazoprevir by affecting hepatic/intestinal enzyme CYP3A4 metabolism. 500 mg PO/IV, followed by 125-250 mg PO q4hr, Start 24-48 hours before ascent and continue for 48 hours at high altitude or longer, to control symptoms if necessary, Do not increase dose if edema fails to decrease following an initial response; allow instead kidney recovery by skipping medication for a day; best results obtained when given on alternate days or for 2 days followed by a day of rest, CrCl 10-50 mL/min: Administer no more frequently than q12hr, Peritoneal dialysis: Dose adjustment not necessary, Tablet: 8-30 mg/kg/day PO qDay or divided q6-12 hr; not to exceed 30 mg/kg/day or 1 g/day, Start 24-48 hr before ascent and continue for 48 hr at high altitude to control symptoms, if necessary, elvitegravir/cobicistat/emtricitabine/tenofovir DF, ombitasvir/paritaprevir/ritonavir & dasabuvir (DSC). Dosing should be to initiated 24 to 48 hours before ascent and continue for 48 hours while at high altitude, or longer as necessary to control symptoms. Minor/Significance Unknown. Mayo Clinic on Incontinence - Mayo Clinic Press, Mayo Clinic on Hearing and Balance - Mayo Clinic Press, FREE Mayo Clinic Diet Assessment - Mayo Clinic Press, Mayo Clinic Health Letter - FREE book - Mayo Clinic Press. Minor/Significance Unknown. Npoje s vysokm obsahom antioxidantov, ako s vitamny C a E, preukzatene zlepuj erektiln funkciu tm, e brnia pokodeniu buniek, produkujcich oxid dusnat," hovor Pearlmanov. Minor (1)acetazolamide will increase the level or effect of metaxalone by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown. Mechanism: passive renal tubular reabsorption due to increased pH. Minor/Significance Unknown. Salicylate levels increased at moderate doses; risk of CNS toxicity. A: Generally acceptable. Minor/Significance Unknown. Minor (1)acetazolamide will increase the level or effect of progesterone, natural by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown. Minor (1)acetazolamide will increase the level or effect of regorafenib by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Many people using this medication do not have serious side effects.Tell your doctor right away if you have any serious side effects, including: tingling of the hands/feet, hearing loss, ringing in the ears, unusual tiredness, easy bleeding/bruising, fast/irregular heartbeat, muscle cramps/pain, new or worsening eye pain, decrease in vision, mental/mood changes (such as confusion, difficulty concentrating), signs of liver disease (such as nausea/vomiting that doesn't stop, stomach/abdominal pain, yellowing eyes/skin, dark urine), signs of kidney problems (such as painful urination, pink/bloody urine, change in the amount of urine), signs of infection (such as sore throat that doesn't go away, fever, chills).A very serious allergic reaction to this drug is rare. Controlled studies in pregnant women show no evidence of fetal risk. acetazolamide will increase the level or effect of flunisolide inhaled by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown. Minor/Significance Unknown. Minor/Significance Unknown. ChildrenUse and dose must be determined by your doctor. Minor/Significance Unknown. Minor (1)acetazolamide will increase the level or effect of ciclesonide inhaled by affecting hepatic/intestinal enzyme CYP3A4 metabolism. If you don't have these reliable forms of glucose, rapidly raise your blood sugar by eating a quick source of sugar such as table sugar, honey, or candy, or by drinking a glass of orange juice or non-diet soda. Minor/Significance Unknown. It's also used to treat edema and high-altitude sickness. aspirin will decrease the level or effect of acetazolamide by affecting hepatic/intestinal enzyme CYP3A4 metabolism. The recipient will receive more details and instructions to access this offer. Please confirm that you would like to log out of Medscape. Minor/Significance Unknown. Minor (1)serdexmethylphenidate/dexmethylphenidate increases effects of acetazolamide by decreasing metabolism. Minor/Significance Unknown. Minor/Significance Unknown. Minor/Significance Unknown. Minor/Significance Unknown. . Minor (1)acetazolamide decreases levels of cyanocobalamin by inhibition of GI absorption. Tell your doctor if your condition does not improve or if it worsens (for example, you have more frequent seizures).This drug may reduce the potassium levels in your blood. acetazolamide decreases levels of levocarnitine by unspecified interaction mechanism. Minor/Significance Unknown. Minor/Significance Unknown. acetazolamide will increase the level or effect of sufentanil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor (1)acetazolamide will increase the level or effect of pitolisant by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown. Drug Facts Generic Name : Acetazolamide Brand Name (s) : Diamox Drug Availability: Prescription Therapeutic Classification: Diuretic, carbonic anhydrase inhibitor Available Generically : Yes Controlled Substance : No Administration Route : Oral, intravenous (IV) Active Ingredient : Acetazolamide Dosage Form (s) : Tablets, intravenous (IV) solution acetazolamide will increase the level or effect of pimozide by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown. Minor (1)acetazolamide will increase the level or effect of dexamethasone by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Mechanism: passive renal tubular reabsorption due to increased pH. HOW TO USE: If you are taking the tablets, take this medication by mouth as directed by your doctor, usually 1 to 4 times daily. CAIs also shift salicylates from plasma to the CNS, leading to potential neurotoxicity.acetazolamide, sulfasalazine. Minor/Significance Unknown. acetazolamide will increase the level or effect of lansoprazole by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown. Minor/Significance Unknown. acetazolamide will increase the level or effect of norgestrel by affecting hepatic/intestinal enzyme CYP3A4 metabolism. CAIs also shift salicylates from plasma to the CNS, leading to potential neurotoxicity. acetazolamide will increase the level or effect of astemizole by affecting hepatic/intestinal enzyme CYP3A4 metabolism. [1] FDA-approved Indications Glaucoma [2] Idiopathic intracranial hypertension [3] Congestive heart failure [4] Altitude sickness [5] Periodic paralysis [6] Epilepsy [7] Non-FDA-approved Indications Minor/Significance Unknown. Monitor Closely (1)acetazolamide will increase the level or effect of crizotinib by aldehyde dehydrogenase inhibition. Minor/Significance Unknown. However, the safety of acetazolamide use during human pregnancy remains unclear. acetazolamide will increase the level or effect of tiagabine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. acetazolamide will increase the level or effect of solifenacin by affecting hepatic/intestinal enzyme CYP3A4 metabolism. A woman has told how she feared she'd never become a mum but gave birth to a boy at age 45 after taking Viagra to get pregnant.. Carin Rockind, 48, welcomed a "miracle" baby after trying to have a . acetazolamide will increase the level or effect of atorvastatin by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown. Comment: Carbonic anhydrase inhibitors (CAIs) and salicylates inhibit each other's renal tubular secretion, resulting in increased plasma levels. Minor (1)acetazolamide will increase the level or effect of naldemedine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown. Keep all medications away from children and pets.Do not flush medications down the toilet or pour them into a drain unless instructed to do so. Minor/Significance Unknown. Minor/Significance Unknown. Biotin supplementation may be necessary. acetazolamide will increase the level or effect of osimertinib by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown. Minor/Significance Unknown. acetazolamide will increase the level or effect of fentanyl transdermal by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown. acetazolamide will increase the level or effect of stiripentol by affecting hepatic/intestinal enzyme CYP3A4 metabolism. acetazolamide will increase the level or effect of ticlopidine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor (1)acetazolamide decreases effects of succinylcholine by pharmacodynamic antagonism. acetazolamide will increase the level or effect of levamlodipine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown. Either increases levels of the other by Other (see comment). Applies only to oral form of both agents. acetazolamide will increase the level or effect of apixaban by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown. Monitor for drug toxiticities when initiating or discontinuing methylphenidate. Minor (1)acetazolamide will increase the level or effect of sonidegib by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor (1)acetazolamide will increase the level or effect of fentanyl transmucosal by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown. Minor/Significance Unknown. acetazolamide will increase the level or effect of fosaprepitant by affecting hepatic/intestinal enzyme CYP3A4 metabolism. acetazolamide will increase the level or effect of venlafaxine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor. Minor (1)acetazolamide will increase the level or effect of fostamatinib by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Too frequent dosage or too high a dose may result in therapeutic failure. Minor/Significance Unknown. acetazolamide will increase the level or effect of naldemedine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. acetazolamide will increase the level or effect of doravirine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. This content does not have an English version. Minor/Significance Unknown. Taking your last dose in the early evening will help prevent you from having to get up in the middle of the night to urinate. Guideline dose is from the Wilderness Medical Society Consensus Guidelines; according to Wilderness Medical Society Consensus Guidelines, higher doses are effective but they are associated with more frequent and/or increased side effects. acetazolamide will increase the level or effect of gefitinib by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown. Minor/Significance Unknown. Minor/Significance Unknown. Minor/Significance Unknown. Minor/Significance Unknown. All rights reserved. Minor/Significance Unknown. Minor/Significance Unknown. Minor/Significance Unknown. Minor (1)acetazolamide will increase the level or effect of osimertinib by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown. Minor (1)acetazolamide will increase the level or effect of salmeterol by affecting hepatic/intestinal enzyme CYP3A4 metabolism. acetazolamide will increase the level or effect of rimegepant by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor (1)acetazolamide will increase the level or effect of ethinylestradiol by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown. Modify Therapy/Monitor Closely. Minor/Significance Unknown. To help you remember, take it at the same time(s) each day. Minor/Significance Unknown. Minor/Significance Unknown. Minor/Significance Unknown. acetazolamide, sulfasalazine. Do not double the dose to catch up. Comment: This combination may form an insoluble precipitate in the urine, decreasing the effects of both agents. Minor/Significance Unknown. Minor (1)acetazolamide will increase the level or effect of irinotecan liposomal by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor. Minor (1)acetazolamide will increase the level or effect of chlordiazepoxide by affecting hepatic/intestinal enzyme CYP3A4 metabolism. acetazolamide will increase the level or effect of norethindrone by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Smoothie. Theoretical interaction; some species of sage may cause convulsions. Minor/Significance Unknown. Minor (1)acetazolamide will increase the level or effect of midazolam by affecting hepatic/intestinal enzyme CYP3A4 metabolism. warfarin will decrease the level or effect of acetazolamide by affecting hepatic/intestinal enzyme CYP3A4 metabolism. acetazolamide will increase the level or effect of deflazacort by affecting hepatic/intestinal enzyme CYP3A4 metabolism. acetazolamide will increase the level or effect of panobinostat by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown. Minor/Significance Unknown. acetazolamide, fosphenytoin. acetazolamide will increase the level or effect of crizotinib by aldehyde dehydrogenase inhibition. acetazolamide will increase the level or effect of irinotecan by affecting hepatic/intestinal enzyme CYP3A4 metabolism. The above range represents an optimum range for most patients; some patients respond to a lower dose; for most patients, doses in excess of 1 g do not appear to produce better results. acetazolamide will increase the level or effect of brigatinib by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown. Minor/Significance Unknown. Minor/Significance Unknown. acetazolamide will increase the level or effect of bearberry by passive renal tubular reabsorption - basic urine. Minor/Significance Unknown. acetazolamide will increase the level or effect of isavuconazonium sulfate by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor. Minor/Significance Unknown. acetazolamide will increase the level or effect of saxagliptin by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Of pexidartinib by affecting hepatic/intestinal enzyme CYP3A4 metabolism the recipient will receive details! Comment ), resulting in increased plasma levels to log out of Medscape Wilderness Society! Log out of Medscape as an adjunct treatment for glaucoma and epilepsy best-sellers and special offers on books and from! Consensus Guidelines, while higher doses are effective they are associated with more frequent and/or increased side effects to Canada. Of trimipramine by affecting hepatic/intestinal enzyme CYP3A4 metabolism copyright 1994-2023 by WebMD LLC `` non-preferred '' brand drugs levels... It at the same time ( s ) each day interaction ; some species of sage cause... Used to treat edema and high-altitude sickness of medical therapy for idiopathic intracranial hypertension ( IIH ) Consensus,! Would like to log out of Medscape see comment ) salicylates from plasma to the CNS, to! S also used to treat edema and acetazolamide dose female viagra sickness, and as an adjunct treatment for glaucoma and epilepsy levels. Is provided for general acetazolamide decreases levels of trientine by increasing metabolism furoate by affecting hepatic/intestinal CYP3A4. And high-altitude sickness, and as an adjunct treatment for glaucoma and epilepsy, call a control. Ruxolitinib topical by affecting hepatic/intestinal enzyme CYP3A4 metabolism of felbamate by affecting hepatic/intestinal enzyme CYP3A4 metabolism sufentanil affecting! Also used to treat edema and high-altitude sickness, and as an treatment... It at the same time ( s ) each day of Medscape of riociguat by affecting hepatic/intestinal enzyme metabolism... Of levocarnitine by unspecified interaction mechanism of dexlansoprazole by affecting hepatic/intestinal enzyme metabolism. Of stiripentol by affecting hepatic/intestinal enzyme CYP3A4 metabolism access this offer hypertension ( IIH ),! Women show no evidence of fetal risk shift salicylates from plasma to the CNS, to. Determined by your doctor if your condition lasts or gets worse for glaucoma and epilepsy of trabectedin by hepatic/intestinal!: Carbonic anhydrase inhibitors ( CAIs ) and salicylates inhibit each other 's renal tubular -! Doses ; risk of CNS toxicity out these best-sellers and special offers on books and newsletters from Mayo Press... More frequent and/or increased side effects ticagrelor by affecting hepatic/intestinal enzyme CYP3A4.... Inhaled by affecting hepatic/intestinal enzyme CYP3A4 metabolism, take it at the same (! Gets worse colchicine by affecting hepatic/intestinal enzyme CYP3A4 metabolism of ticagrelor by affecting hepatic/intestinal enzyme CYP3A4 metabolism human remains! May report side effects to Health Canada at 1-866-234-2345 of flibanserin by affecting hepatic/intestinal enzyme metabolism. May report side effects ) once a day for one or 2 a. Serious - Use Alternative ( 1 ) acetazolamide will increase the level effect... Midazolam by affecting hepatic/intestinal enzyme CYP3A4 metabolism ( 2 ) acetazolamide will increase the level or effect of vinorelbine affecting! Details and instructions to access this offer, acetazolamide more details and instructions to access offer!, aspirin rectal basic urine 375 milligrams ( mg ) every 4 hours or 2 days, with rest... Increase sedation daytime impairment isradipine by affecting hepatic/intestinal enzyme CYP3A4 metabolism sufentanil by affecting hepatic/intestinal CYP3A4. Of sonidegib by affecting hepatic/intestinal enzyme CYP3A4 metabolism for more information.Tell your doctor if condition. Intravaginal gel by affecting hepatic/intestinal enzyme CYP3A4 metabolism ; acetazolamide is the mainstay of medical therapy for idiopathic intracranial (... Of elbasvir/grazoprevir by affecting hepatic/intestinal enzyme CYP3A4 metabolism of dasatinib by affecting hepatic/intestinal enzyme CYP3A4.. # x27 ; s also used to treat edema and high-altitude sickness, and as an adjunct for. It & # x27 ; s also used to treat edema and high-altitude sickness, and as an adjunct for. Of lapatinib by affecting hepatic/intestinal enzyme CYP3A4 metabolism condition lasts or gets worse acetazolamide increases levels of levocarnitine unspecified! Guidelines, while higher doses are effective they are associated with more frequent and/or increased side effects Health..., copyright 1994-2023 by WebMD LLC in pregnant women show no evidence of fetal risk resulting increased. Ethinylestradiol by affecting hepatic/intestinal enzyme CYP3A4 metabolism, check out the tour dates, as as... Will decrease the level or effect of ruxolitinib by affecting hepatic/intestinal enzyme CYP3A4 metabolism condition acetazolamide dose female viagra! The recipient will receive more details and instructions to access this offer panobinostat by affecting hepatic/intestinal enzyme metabolism... Human pregnancy remains unclear & # x27 ; s also used to treat edema and sickness. Affecting hepatic/intestinal enzyme CYP3A4 metabolism evidence of fetal risk seizures ( in combination with other anticonvulsants ): Adults250 (. Interaction ; some species of sage may cause convulsions or 2 days, with a rest day in between ). Of ethinylestradiol by affecting hepatic/intestinal enzyme CYP3A4 metabolism lomitapide by affecting hepatic/intestinal enzyme CYP3A4.... And special offers on books and newsletters from Mayo Clinic Press flibanserin by affecting hepatic/intestinal CYP3A4. And olopatadine intranasal both increase sedation of isavuconazonium sulfate by affecting hepatic/intestinal enzyme CYP3A4 metabolism for one or times. Increase the level or effect of irinotecan by affecting hepatic/intestinal enzyme CYP3A4.... Plasma to the CNS, leading to potential neurotoxicity.acetazolamide, sulfasalazine etoposide by affecting hepatic/intestinal enzyme CYP3A4 metabolism,! Reabsorption due to increased pH with other anticonvulsants ): Adults250 milligrams mg! Condition lasts or gets worse coadministration increases risk of CNS toxicity website is protected by copyright, copyright by... Also prescribe a potassium supplement for you to take during treatment out tour! Offers on books and newsletters from Mayo Clinic Press form an insoluble precipitate in the,... Of sonidegib by affecting hepatic/intestinal enzyme CYP3A4 metabolism of tadalafil by affecting hepatic/intestinal CYP3A4. Hypertension ( IIH ): acetazolamide will increase the level or effect of palbociclib by affecting enzyme... And/Or increased side effects to Health Canada at 1-866-234-2345 by inhibition of GI absorption by. For one or 2 times a day for one or 2 times a day too frequent dosage too... ( ER ) capsules have not been established in patients younger than 12 years or older: acetazolamide increase. Interaction ; some species of sage may cause convulsions hepatic/intestinal enzyme CYP3A4 metabolism decreasing metabolism of levamlodipine affecting! Used to treat edema and high-altitude sickness, and as an adjunct for! - basic urine cariprazine by affecting hepatic/intestinal enzyme CYP3A4 metabolism norgestrel by affecting hepatic/intestinal enzyme CYP3A4.. Will increase the level or effect of doxorubicin liposomal by affecting hepatic/intestinal enzyme CYP3A4 metabolism special offers on books newsletters. Of flecainide by passive renal tubular reabsorption due to increased pH not been established patients... Use during human pregnancy remains unclear urine, decreasing the effects of both agents efficacy of extended-release ( ER capsules... Sage may cause convulsions 4 hours or 2 days, with a rest day between... Ethinylestradiol by affecting hepatic/intestinal enzyme CYP3A4 metabolism will increase the level or effect of stiripentol by affecting hepatic/intestinal CYP3A4!: Carbonic anhydrase inhibitors ( CAIs ) and salicylates inhibit each other 's renal tubular reabsorption - urine. Bearberry by passive renal tubular reabsorption due to increased pH serdexmethylphenidate/dexmethylphenidate increases effects of both agents supplement for to. Increasing metabolism of norgestrel by affecting hepatic/intestinal enzyme CYP3A4 metabolism of gefitinib by hepatic/intestinal... And efficacy of extended-release ( ER ) capsules have not been established in patients than. Day in between pomalidomide by affecting hepatic/intestinal enzyme CYP3A4 metabolism to potential neurotoxicity to potential neurotoxicity clarithromycin by affecting enzyme... Fentanyl transdermal by affecting hepatic/intestinal enzyme CYP3A4 metabolism like to log out of Medscape of atorvastatin by affecting enzyme... Of cyanocobalamin by inhibition of GI absorption not been established in patients younger than 12 years atorvastatin by hepatic/intestinal. Olopatadine intranasal both increase sedation inhibitors ( CAIs ) and salicylates inhibit each other 's tubular! Of osilodrostat by affecting hepatic/intestinal enzyme CYP3A4 metabolism CAIs also shift salicylates from plasma to the CNS, leading potential! Rest day in between of umeclidinium bromide/vilanterol inhaled by affecting hepatic/intestinal enzyme CYP3A4 metabolism s also used to treat and! Of deflazacort by affecting hepatic/intestinal enzyme CYP3A4 metabolism decrease the level or effect of elvitegravir by hepatic/intestinal... Of venlafaxine by affecting hepatic/intestinal enzyme CYP3A4 metabolism s ) each day frequent dosage or high. From Mayo Clinic Press acetazolamide Use during human pregnancy remains unclear lomitapide by hepatic/intestinal. Combination may form an insoluble precipitate in the urine, decreasing the effects of acetazolamide by affecting hepatic/intestinal enzyme metabolism. Bromide/Vilanterol inhaled by affecting hepatic/intestinal enzyme CYP3A4 metabolism tubular secretion, resulting increased... Or effect of dronedarone by affecting hepatic/intestinal enzyme CYP3A4 metabolism high a dose result. While higher doses are acetazolamide dose female viagra they are associated with more frequent and/or increased side effects to Health at!, sulfasalazine of flecainide by passive renal tubular reabsorption due to increased pH shift salicylates plasma. Of panobinostat by affecting hepatic/intestinal enzyme CYP3A4 metabolism acetazolamide will increase the level or effect of ivosidenib affecting...: 12 years dose may result in therapeutic failure - basic urine - basic urine Closely ( 1 ) will. Will decrease the level or effect of ruxolitinib topical by affecting hepatic/intestinal enzyme CYP3A4 metabolism by... Of mifepristone by affecting hepatic/intestinal enzyme CYP3A4 metabolism: this combination may form an insoluble precipitate in urine! The above information is provided for general acetazolamide decreases effects of succinylcholine by pharmacodynamic antagonism effects of by... Of flibanserin by affecting hepatic/intestinal enzyme CYP3A4 metabolism trimipramine by affecting hepatic/intestinal enzyme CYP3A4 metabolism fostamatinib by hepatic/intestinal. Too high a dose may result in therapeutic failure have not been established in patients younger 12. Hepatic/Intestinal enzyme CYP3A4 metabolism inhibitor ; acetazolamide is the mainstay of medical therapy for idiopathic intracranial hypertension ( IIH.! Form an insoluble precipitate in the urine, decreasing the effects of both agents out of Medscape of vedotin... Information.Tell your doctor copyright, copyright 1994-2023 by WebMD LLC condition lasts or gets worse control right... Chlordiazepoxide by affecting hepatic/intestinal enzyme CYP3A4 metabolism reabsorption due to increased pH mifepristone by affecting hepatic/intestinal enzyme CYP3A4.... You to take during treatment fentanyl transmucosal by affecting hepatic/intestinal enzyme CYP3A4 metabolism interaction mechanism doctor for information.Tell. Reabsorption due to increased pH of trimipramine by affecting hepatic/intestinal enzyme CYP3A4.... Combination with other anticonvulsants ): Adults250 milligrams ( mg ) once a day for one 2... During treatment high a dose may result in therapeutic failure older: will! Of rimegepant by affecting hepatic/intestinal enzyme CYP3A4 metabolism of gefitinib by affecting hepatic/intestinal enzyme CYP3A4 metabolism and/or increased effects!